Patents by Inventor Uday R. Khire

Uday R. Khire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MEK INHIBITORS FOR TREATING CARDIOMYOPATHIES AND RELATED CONDITIONS
    Publication number: 20150250762
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A, and A? are described herein. Formula (I) compounds can be used in pharmaceutical compositions, useful for the treatment of disease, in particular cardiovascular conditions and more particularly cardiomyopathies, as well as other related conditions.
    Type: Application
    Filed: April 10, 2015
    Publication date: September 10, 2015
    Inventors: Howard J. Worman, Antoine Muchir, Uday R. Khire, Mahendra Devichand Chordia, Barry Hart
  • MEK inhibitors useful in the treatment of diseases
    Patent number: 9034861
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A? are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: May 19, 2015
    Assignee: Allomek Therapeutics LLC
    Inventors: Uday R. Khire, Mahendra Devichand Chordia
  • DIAMINOPTERIDINE DERIVATIVES
    Publication number: 20120283219
    Abstract: The present invention relates novel diaminopteridine derivatives, their compositions and method of treatment comprising the same for use as anti-infectives.
    Type: Application
    Filed: March 25, 2010
    Publication date: November 8, 2012
    Inventors: Philip D.G. Coish, Phil Wickens, Brian R. Dixon, David Osterman, Uday R. Khire, Manuel Navia, Judd Berman, Harpreet Kaur, Jeffrey Wilson, Dennis Underwood
  • NOVEL MEK INHIBITORS USEFUL IN THE TREATMENT OF DISEASES
    Publication number: 20120208859
    Abstract: The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A? are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
    Type: Application
    Filed: October 13, 2009
    Publication date: August 16, 2012
    Applicant: ALLOSTEM THERAPEUTICS LLC
    Inventors: Uday R. Khire, Mahendra Devichand Chordia
  • ?-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
    Patent number: 7897623
    Abstract: This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Grant
    Filed: August 27, 2007
    Date of Patent: March 1, 2011
    Assignee: Bayer Healthcare LLC
    Inventors: Bernd Riedl, Jacques Dumas, Uday R. Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley